prevention brca1-mediated mammary tumorigenesis mice progesterone antagonist
women mutations breast cancer susceptibility gene brca1 predisposed breast ovarian cancers brca1 protein suppresses tumor development specifically ovarian hormone sensitive tissues remains unclear demonstrate mammary glands nulliparous brca1/p53-deficient mice accumulate lateral branches undergo extensive alveologenesis phenotype occurs pregnancy wild-type mice progesterone receptors estrogen receptors overexpressed mutant mammary epithelial cells defect degradation proteasome pathway treatment brca1/p53-deficient mice progesterone antagonist mifepristone ru prevented mammary tumorigenesis findings reveal tissue-specific function brca1 protein raise possibility antiprogesterone treatment may useful breast cancer prevention individuals brca1 mutations
